Citius Pharmaceuticals Inc. (CTXR) Declined -13.66% or -0.53 To Price $3.35 On Friday


Citius Pharmaceuticals Inc. (CTXR) declined -13.66% or -0.53 to $3.35. It is approximately 92593 shares traded, which is 153.46% compare to the average total volume 60336. The market cap of CTXR is $33.42 million. The year to date change is -4.67%. The 52 week price range is from $2.56 to $14.62. Price of CTXR have changed -1.27% during last week. It have changed -1.02% over last month, -21.62% over last 3 months, 30.20% over last 6 months and -52.97% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CTXR is 4.35. It is 29.85% above current price. The 200-day Moving Averages for CTXR is 4.65. It is 38.81% above current price. The 52-week High is 14.62. It is 336.42% from the current price. The 52-week Low is 2.56. It is -23.58% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CTXR is 0.15 on 2018-01-12. Short % to float is 0.17%. There are some statistics of CTXR. It is has market cap $33.42 million. The share outstanding is 9.98 million. The average volume is 60336. The percent of top 15 Institution holding is 9.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CTXR is -53.65%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CTXR is -44.79%.


Tags:

Share this post